Please use this identifier to cite or link to this item:
http://localhost:80/xmlui/handle/123456789/1916
Title: | In search of an alleviating drug in the management of mastalgia, danazol or evening primerose oil: our recent experience |
Authors: | Iftikhar, Javeria Zubair, Rabbia Habib, Lubna Ali, Mir Arsalan Khan, Arfeen Azam Saeed, Nida |
Keywords: | Medical and Health Sciences Mastalgia Danazol Evening prime rose oil Cyclical Non-cyclical |
Issue Date: | 2-Feb-2019 |
Publisher: | Pakistan Journal of Surgery |
Abstract: | Objective: To study the recent outcomes of management of mastalgia treated by Danazol and Evening Primerose oil. Study design: Descriptive observational study Study sett ing: Department of Surgery, Hamdard University Hospital Duration: For a period of 12 months: from December 2016 to December 2017 Material and Methods: Th e candidates were selected on basis of double blinded, consecutive sampling. Females with complains of Mastalgia, coinciding with our inclusion criteria were administered danazol, evening primerose oil in divided doses for a period of 6 weeks and they were assessed for pain alleviation by the Cardiff Breast Pain score. Results: In our study the results showed Danazol to be signifi cantly eff ective in the management of Mastalgia as compared to the effi cacy of evening primrose oil. In Group-A, the average Cardiff breast pain score of those candidates receiving Danazol at 4 weeks was 2.19 and at 12 weeks was 1.23, which signifi es the effi cacy of the drug in relieving pain. Th e Mean Cardiff breast pain score of group-B at 4 weeks was 2.77 and at 12 weeks was 2.03 reinforcing its use not strongly benefi cial for patients in mastalgia. Conclusion: We concluded that although with mild, tolerable and reversible adverse eff ects Danazol has a promising role in management of cyclical in women. |
URI: | http://142.54.178.187:9060/xmlui/handle/123456789/1916 |
ISSN: | 0258-8552 |
Appears in Collections: | Journals |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.